Research Commercialization Academy (BETA 0.01)

Back Office Services for NCET2.org

 
Ria Ancheta-Adrias (staff3) Profile Page
Ria Ancheta-Adrias (staff3)

My Articles



No blog articles found

My Interesting Links Archive

Author: Not Specified



Source: PR Newswire



Interest: Amplimmune, Inc. announced that it has entered into a broad strategic alliance with GlaxoSmithKline (GSK) to further develop PD-1 targeting therapies that may be effective in the treatment of cancer and other diseases.



Link: http://www.prnewswire.com/news-releases/glaxosmithkline-and-amplimmune-form-global-strategic-collaboration-99938599.html

Contact Info

Ria Ancheta-Adrias
Ria
Ancheta-Adrias
staff3
District of Columbia
20006
Non Profit Employee (not Researcher)
-
-
ncet2.org
-
No

Education

-
-

Groups

GroupDESCASCCategoryDESCASCCreatorDESCASCTypeDESCASCMembersJoinedDESCASC
DTRA Webinar, Dec 2012
DTRA Webinar, Dec 2012
general
general

Ria Ancheta-Adrias (staff3)
Open14912/18/2012
Research Commercialization Course October 2012
Research Commercialization Course October 2012
general
general

Ria Ancheta-Adrias (staff3)
Open61811/07/2012
Contract Accords Series
Contract Accords Series
general
general

Ria Ancheta-Adrias (staff3)
Open36009/27/2012
Patents Webinar Series
Patents Webinar Series
general
general

Ria Ancheta-Adrias (staff3)
Open134709/18/2012
Global Corporate Venturing
Global Corporate Venturing
general
general

Ria Ancheta-Adrias (staff3)
Open45106/05/2012
<< Start < Prev [1] 2 3 4 Next > End >>

Awards

Loading... Loading...

My Certificates

Access Denied

My Courses

Access Denied

My Startups